A. Kolyada

Soluble analog of ApoER2 targeting beta2‐glycoprotein I in immune complexes counteracts hypertension in lupus‐prone mice with spontaneous antiphospholipid syndrome

P. Kang, N. Beglova, D. A. Barrios, 2016, Journal of thrombosis and haemostasis : JTH.

An A1–A1 mutant with improved binding and inhibition of β2GPI/antibody complexes in antiphospholipid syndrome

N. Beglova, A. Kolyada, I. Karageorgos, 2015, The FEBS journal.

Dimerized Domain V of Beta2-Glycoprotein I Is Sufficient to Upregulate Procoagulant Activity in PMA-Treated U937 Monocytes and Require Intact Residues in Two Phospholipid-Binding Loops

N. Beglova, D. A. Barrios, A. Kolyada, 2017, Antibodies.

Identification of the binding site for fondaparinux on Beta2-glycoprotein I.

A. De Biasio, N. Beglova, A. Kolyada, 2013, Biochimica et biophysica acta.

A Novel Dimeric Inhibitor That Targets Dimeric ß2GPI In ß2GPI/Anti-ß2GPI Antibody Complexes.

N. Beglova, A. D. Biasio, Chang-Jin Lee, 2010 .

Inhibition of thrombotic properties of persistent autoimmune anti-β2GPI antibodies in the mouse model of antiphospholipid syndrome.

N. Beglova, A. Kolyada, A. Porter, 2014, Blood.

A Novel Dimeric Inhibitor Targeting Beta2GPI in Beta2GPI/Antibody Complexes Implicated in Antiphospholipid Syndrome

A. De Biasio, N. Beglova, Chang-Jin Lee, 2010, PloS one.